Girisopam

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Girisopam
Girisopam.svg
Systematic (IUPAC) name
1-(3-chlorophenyl)- 7,8-dimethoxy- 4-methyl- 5H-2,3-benzodiazepine
Clinical data
Legal status
?
Identifiers
CAS number 82230-53-3 YesY
ATC code None
PubChem CID 71257
ChemSpider 64387 YesY
UNII 2LP301A921 YesY
ChEMBL CHEMBL1915065
Chemical data
Formula C18H17ClN2O2 
Mol. mass 328.79
 YesY (what is this?)  (verify)

Girisopam[1] (GYKI-51189) is a drug which is a 2,3-benzodiazepine derivative, related to tofisopam.[2] It has selective anxiolytic action with no sedative, anticonvulsant or muscle relaxant effects.[3][4][5]

See also[edit]

References[edit]

  1. ^ US Patent 4322346
  2. ^ Psychotropics.dk
  3. ^ Andrási F, Horváth K, Sineger E, Berzsenyi P, Borsy J, Kenessey A, Tarr M, Láng T, Kórösi J, Hámori T. Neuropharmacology of a new psychotropic 2,3-benzodiazepine. Arzneimittelforschung. 1987 Oct;37(10):1119-24.
  4. ^ Horváth K, Andrási F, Botka P, Hámori T. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone. Acta Physiologica Hungarica. 1992;79(2):153-61.
  5. ^ Horváth EJ, Salamon C, Bakonyi A, Fekete MI, Palkovits M. [(3)H]-girisopam, a novel selective benzodiazepine for the 2, 3-benzodiazepine binding site. Brain Research. Brain Research Protocols. 1999 Jul;4(2):230-5.